Looped host defense peptide CLP-19 binds to microtubules and inhibits surface expression of TLR4 on mouse macrophages

Journal of Immunology

Volumn 190, Issue 12, 2013, Pages 6083-6092

  Li, Di ^a   Liu, Yao ^a   Yang, Ya ^a   Chen, Jian Hong ^a   Yang, Jie ^a   Zou, Lin Yun ^a   Tian, Zhi Qiang ^a   Lv, Jun ^a   Xia, Pei Yuan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; BETA TUBULIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LOOPED HOST DEFENSE PEPTIDE CLP 19B; LOOPED HOST DEFENSE PEPTIDE CLP 19F; PEPTIDE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ALPHA HELIX; ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEPOLYMERIZATION; ENDOPLASMIC RETICULUM; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; IMMUNOREGULATION; MACROPHAGE; MICROTUBULE; MICROTUBULE ASSEMBLY; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; WESTERN BLOTTING;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; ARTHROPOD PROTEINS; BLOTTING, WESTERN; CELL LINE; CELL MEMBRANE; CHROMATOGRAPHY, AFFINITY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICROTUBULES; PEPTIDES, CYCLIC; PROTEIN TRANSPORT; TOLL-LIKE RECEPTOR 4; TUBULIN;

EID: 84879096124     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203167     Document Type: Article

References (47)

1. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420: 885-891. (Pubitemid 36019643)
2. Brodsky, I., and R. Medzhitov. 2007. Two modes of ligand recognition by TLRs. Cell 130: 979-981. (Pubitemid 47410282)
3. Kagan, J. C. 2010. Recycling endosomes and TLR signaling: the Rab11 GTPase leads the way. Immunity 33: 578-580.
4. Waage, A., P. Brandtzaeg, A. Halstensen, P. Kierulf, and T. Espevik. 1989. The complex pattern of cytokines in serum from patients with meningococcal septic shock: association between interleukin 6, interleukin 1, and fatal outcome. J. Exp. Med. 169: 333-338. (Pubitemid 19035565)
5. Cai, B., E. A. Deitch, and L. Ulloa. 2010. Novel insights for systemic inflammation in sepsis and hemorrhage. Mediators Inflamm. 2010: 642462.
6. Hotchkiss, R. S., and I. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348: 138-150. (Pubitemid 36056721)
7. Heumann, D., M. P. Glauser, and T. Calandra. 1998. Molecular basis of host-pathogen interaction in septic shock. Curr. Opin. Microbiol. 1: 49-55. (Pubitemid 128428042)
8. Nguyen, H. B., E. P. Rivers, F. M. Abrahamian, G. J. Moran, E. Abraham, S. Trzeciak, D. T. Huang, T. Osborn, D. Stevens, and D. A. Talan; Emergency Department Sepsis Education Program and Strategies to Improve Survival (ED-SEPSIS) Working Group. 2006. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann. Emerg. Med. 48: 28-54.
9. Takeyama, N., H. Noguchi, A. Hirakawa, H. Kano, K. Morino, T. Obata, T. Sakamoto, F. Tamai, H. Ishikura, Y. Kase, et al Japan Sepsis Study Group. 2012. Time to initiation of treatment with polymyxin B cartridge hemoperfusion in septic shock patients. Blood Purif. 33: 252-256.
10. Iba, T., K. Okamoto, S. Kawasaki, E. Nakarai, and T. Miyasho. 2011. Effect of hemoperfusion using polymyxin B-immobilized fibers on non-shock rat sepsis model. J. Surg. Res. 171: 755-761.
11. Schultz, H., and J. P. Weiss. 2007. The bactericidal/permeability- increasing protein (BPI) in infection and inflammatory disease. Clin. Chim. Acta 384: 12-23. (Pubitemid 47247427)
12. Lennartsson, A., K. Pieters, K. Vidovic, and U. Gullberg. 2005. A murine antibacterial ortholog to human bactericidal/permeability-increasing protein (BPI) is expressed in testis, epididymis, and bone marrow. J. Leukoc. Biol. 77: 369-377. (Pubitemid 40289567)
13. Weiss, J. 2003. Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): structure, function and regulation in host defence against Gram-negative bacteria. Biochem. Soc. Trans. 31: 785-790. (Pubitemid 36981128)
14. Suzuki, K., T. Murakami, K. Kuwahara-Arai, H. Tamura, K. Hiramatsu, and I. Nagaoka. 2011. Human anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells. Int. Immunol. 23: 185-193.
15. Into, T., M. Inomata, K. Shibata, and Y. Murakami. 2010. Effect of the antimicrobial peptide LL-37 on Toll-like receptors 2-, 3- and 4-triggered expression of IL-6, IL-8 and CXCL10 in human gingival fibroblasts. Cell. Immunol. 264: 104-109.
16. Nijnik, A., J. Pistolic, A. Wyatt, S. Tam, and R. E. W. Hancock. 2009. Human cathelicidin peptide LL-37 modulates the effects of IFN-g on APCs. J. Immunol. 183: 5788-5798.
17. Filewod, N. C. J., J. Pistolic, and R. E. W. Hancock. 2009. Low concentrations of LL-37 alter IL-8 production by keratinocytes and bronchial epithelial cells in response to proin£ammatory stimuli. FEMS Immunol. Med. Microbiol. 56: 233-240.
18. Lentschat, A., H. Karahashi, K. S. Michelsen, L. S. Thomas, W. Zhang, S. N. Vogel, and M. Arditi. 2005. Mastoparan, a G protein agonist peptide, differentially modulates TLR4- and TLR2-mediated signaling in human endothelial cells and murine macrophages. J. Immunol. 174: 4252-4261. (Pubitemid 40396006)
19. Pristovsek, P., K. Fehér, L. Szilágyi, and J. Kidric. 2005. Structure of a synthetic fragment of the LALF protein when bound to lipopolysaccharide. J. Med. Chem. 48: 1666-1670. (Pubitemid 40364573)
20. Vallespi, M. G., M. Colas, H. Garay, O. Reyes, and M. J. Araña. 2004. Differential regulation of Th1/Th2 in relevant tissues for sepsis pathogenesis with a Limulus anti-LPS factor-derived peptide increases survival in Gram-positive sepsis. Int. Immunopharmacol. 4: 1343-1351. (Pubitemid 39094408)
21. Vallespi, M. G., J. C. Alvarez-Obregón, I. Rodriguez-Alonso, T. Montero, H. Garay, O. Reyes, and M. J. Arańa. 2003. A Limulus anti-LPS factor-derived peptide modulates cytokine gene expression and promotes resolution of bacterial acute infection in mice. Int. Immunopharmacol. 3: 247-256. (Pubitemid 36183383)
22. Ren, J. D., J. S. Gu, H. F. Gao, P. Y. Xia, and G. X. Xiao. 2008. A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo. Int. Immunopharmacol. 8: 775-781.
23. Liu, Y., B. Ni, J. D. Ren, J. H. Chen, Z. Q. Tian, M. Tang, D. Li, and P. Xia. 2011. Cyclic Limulus anti-lipopolysaccharide (LPS) factor-derived peptide CLP-19 antagonizes LPS function by blocking binding to LPS binding protein. Biol. Pharm. Bull. 34: 1678-1683.
24. Lau, Y. E., A. Rozek, M. G. Scott, D. L. Goosney, D. J. Davidson, and R. E. W. Hancock. 2005. Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect. Immun. 73: 583-591. (Pubitemid 40041153)
25. Downing, K. H., and E. Nogales. 1998. Tubulin structure: insights into microtubule properties and functions. Curr. Opin. Struct. Biol. 8: 785-791. (Pubitemid 29004677)
26. Downing, K. H., and E. Nogales. 1998. New insights into microtubule structure and function from the atomic model of tubulin. Eur. Biophys. J. 27: 431-436. (Pubitemid 28414883)
27. Jiang, Q., S. Akashi, K. Miyake, and H. R. Petty. 2000. Lipopolysaccharide induces physical proximity between CD14 and Toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-κB. J. Immunol. 165: 3541-3544. (Pubitemid 32057253)
28. Andrä, J., J. Howe, P. Garidel, M. Rössle, W. Richter, J. Leiva-León, I. Moriyon, R. Bartels, T. Gutsmann, and K. Brandenburg. 2007. Mechanism of interaction of optimized Limulus-derived cyclic peptides with endotoxins: thermodynamic, biophysical and microbiological analysis. Biochem. J. 406: 297-307. (Pubitemid 47310960)
29. Kitchens, R. L., and P. A. Thompson. 2005. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J. Endotoxin Res. 11: 225-229. (Pubitemid 41358857)
30. Dunzendorfer, S., H.-K. Lee, K. Soldau, and P. S. Tobias. 2004. Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses. FASEB J. 18: 1117-1119. (Pubitemid 39561542)
31. Matsuda, A., A. Jacob, R. Wu, M. Aziz, W. L. Yang, T. Matsutani, H. Suzuki, K. Furukawa, E. Uchida, and P. Wang. 2012. Novel therapeutic targets for sepsis: regulation of exaggerated inflammatory responses. J. Nippon Med. Sch. 79: 4-18.
32. Lewis, D. H., D. L. Chan, D. Pinheiro, E. Armitage-Chan, and O. A. Garden. 2012. The immunopathology of sepsis: pathogen recognition, systemic inflammation, the compensatory anti-inflammatory response, and regulatory T cells. J. Vet. Intern. Med. 26: 457-482.
33. Christman, J. W., L. H. Lancaster, and T. S. Blackwell. 1998. Nuclear factor κB: a pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Med. 24: 1131-1138. (Pubitemid 28542926)
34. Abraham, E., K. Reinhart, P. Svoboda, A. Seibert, D. Olthoff, A. Dal Nogare, R. Postier, G. Hempelmann, T. Butler, E. Martin, et al. 2001. Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study. Crit. Care Med. 29: 2081-2089. (Pubitemid 33063534)
35. Wu, L. Q., W. Q. Xu, Q. Y. Zhang, H. X. Hu, X. J. Zhu, and D. H. Su. 2008. Antagonistic effects of Limulus anti-lipopolysaccharide factor on high mobility group box-1 in vitro. J. Fujian Med. Univ. 42: 212-215.
36. Downing, K. H., and E. Nogales. 1998. Tubulin and microtubule structure. Curr. Opin. Cell Biol. 10: 16-22. (Pubitemid 28066117)
37. Hornef, M. W., T. Frisan, A. Vandewalle, S. Normark, and A. Richter-Dahlfors. 2002. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J. Exp. Med. 195: 559-570. (Pubitemid 34461501)
38. 2B-adrenergic receptor interaction with tubulin controls its transport from the endoplasmic reticulum to the cell surface. J. Biol. Chem. 286: 14080-14089.
39. Schmoranzer, J., and S. M. Simon. 2003. Role of microtubules in fusion of post-Golgi vesicles to the plasma membrane. Mol. Biol. Cell 14: 1558-1569. (Pubitemid 36547422)
40. Wacker, I., C. Kaether, A. Krömer, A. Migala, W. Almers, and H. H. Gerdes. 1997. Microtubule-dependent transport of secretory vesicles visualized in real time with a GFP-tagged secretory protein. J. Cell Sci. 110: 1453-1463. (Pubitemid 27326664)
41. Niessner, A., S. Steiner, W. S. Speidl, J. Pleiner, D. Seidinger, G. Maurer, J. J. Goronzy, C. M. Weyand, C. W. Kopp, K. Huber, et al. 2006. Simvastatin suppresses endotoxin-induced upregulation of Toll-like receptors 4 and 2 in vivo. Atherosclerosis 189: 408-413. (Pubitemid 44634488)
42. Wang, Y., M. X. Zhang, X. Meng, F. Q. Liu, G. S. Yu, C. Zhang, T. Sun, X. P. Wang, L. Li, Y. Y. Wang, et al. 2011. Atorvastatin suppresses LPS-induced rapid upregulation of Toll-like receptor 4 and its signaling pathway in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 300: H1743-H1752.
43. Bomsel, M., R. Parton, S. A. Kuznetsov, T. A. Schroer, and J. Gruenberg. 1990. Microtubule- and motor-dependent fusion in vitro between apical and basolateral endocytic vesicles from MDCK cells. Cell 62: 719-731.
44. Latz, E., A. Visintin, E. Lien, K. A. Fitzgerald, B. G. Monks, E. A. Kurt-Jones, D. T. Golenbock, and T. Espevik. 2002. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the Toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J. Biol. Chem. 277: 47834-47843. (Pubitemid 36159310)
45. Jackman, R. W., M. G. Rhoads, E. Cornwell, and S. C. Kandarian. 2009. Microtubule-mediated NF-κB activation in the TNF-α signaling pathway. Exp. Cell Res. 315: 3242-3249.
46. Jung, Y. J., J. S. Isaacs, S. Lee, J. Trepel, and L. Neckers. 2003. Microtubule disruption utilizes an NFκB-dependent pathway to stabilize HIF-1α protein. J. Biol. Chem. 278: 7445-7452. (Pubitemid 36800750)
47. Hirokawa, N. 1998. Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science 279: 519-526. (Pubitemid 28067273)